Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

AMDL Signs Distribution Deal

publication date: Oct 12, 2007

AMDL, Inc. reported that its China subsidiary, Jade Pharmaceutical, signed on Heze Mudan Medicals Co. Ltd. to distribute Jade’s Domperidone tablets, a drug used to treat nausea and vomiting. Jade expects the arrangement to add at least $2.3 million annually to sales, which is not insignificant for a company that booked revenues of just $2.4 million in the second quarter of 2007.  More details...

Stock Symbol: (AMEX: ADL)



Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital